| Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy HA Knaus, S Berglund, H Hackl, AL Blackford, JF Zeidner, ... JCI insight 3 (21), 2018 | 148 | 2018 |
| Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1 B Mukherjee, R Mukhopadhyay, B Bannerjee, S Chowdhury, S Mukherjee, ... Proceedings of the National Academy of Sciences 110 (7), E575-E582, 2013 | 92 | 2013 |
| Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells R Mukhopadhyay, S Mukherjee, B Mukherjee, K Naskar, D Mondal, ... International journal for parasitology 41 (13-14), 1311-1321, 2011 | 91 | 2011 |
| Restoration of IFNγR Subunit Assembly, IFNγ Signaling and Parasite Clearance in Leishmania donovani Infected Macrophages: Role of Membrane Cholesterol S Sen, K Roy, S Mukherjee, R Mukhopadhyay, S Roy PLoS pathogens 7 (9), e1002229, 2011 | 75 | 2011 |
| Imipramine Is an Orally Active Drug against Both Antimony Sensitive and Resistant Leishmania donovani Clinical Isolates in Experimental Infection S Mukherjee, B Mukherjee, R Mukhopadhyay, K Naskar, S Sundar, ... PLoS neglected tropical diseases 6 (12), e1987, 2012 | 64 | 2012 |
| Efficacy and mechanism of action of low dose emetine against human cytomegalovirus R Mukhopadhyay, S Roy, R Venkatadri, YP Su, W Ye, E Barnaeva, ... PLoS pathogens 12 (6), e1005717, 2016 | 57 | 2016 |
| Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani A Kulshrestha, V Bhandari, R Mukhopadhyay, V Ramesh, S Sundar, ... Parasitology research 112, 825-828, 2013 | 54 | 2013 |
| The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice S Chowdhury, T Mukherjee, R Mukhopadhyay, B Mukherjee, S Sengupta, ... EMBO Molecular Medicine 4 (10), 1126-1143, 2012 | 53 | 2012 |
| Phase II trial of pembrolizumab after high-dose cytarabine in relapsed/refractory acute myeloid leukemia JF Zeidner, BG Vincent, A Ivanova, D Moore, KP McKinnon, AD Wilkinson, ... Blood cancer discovery 2 (6), 616-629, 2021 | 50 | 2021 |
| Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in … S Mukherjee, B Mukherjee, R Mukhopadhyay, K Naskar, S Sundar, ... The Journal of Immunology 193 (8), 4083-4094, 2014 | 47 | 2014 |
| Metabolic reconfiguration of the central glucose metabolism: a crucial strategy of Leishmania donovani for its survival during oxidative stress AK Ghosh, AH Sardar, A Mandal, S Saini, K Abhishek, A Kumar, B Purkait, ... The FASEB Journal 29 (5), 2081-2098, 2015 | 44 | 2015 |
| Digitoxin Suppresses Human Cytomegalovirus Replication via Na+, K+/ATPase α1 Subunit-Dependent AMP-Activated Protein Kinase and Autophagy Activation R Mukhopadhyay, R Venkatadri, J Katsnelson, R Arav-Boger Journal of virology 92 (6), 10.1128/jvi. 01861-17, 2018 | 36 | 2018 |
| Antimony-resistant Leishmania donovani exploits miR-466i to deactivate host MyD88 for regulating IL-10/IL-12 levels during early hours of infection B Mukherjee, J Paul, S Mukherjee, R Mukhopadhyay, S Das, K Naskar, ... The Journal of Immunology 195 (6), 2731-2742, 2015 | 36 | 2015 |
| Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo YH Fan, S Roy, R Mukhopadhyay, A Kapoor, P Duggal, GL Wojcik, ... Proceedings of the National Academy of Sciences 113 (48), E7818-E7827, 2016 | 35 | 2016 |
| Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia S Rutella, J Vadakekolathu, F Mazziotta, S Reeder, TO Yau, ... The Journal of Clinical Investigation 132 (21), 2022 | 33 | 2022 |
| Factors affecting colonization of rice leaves by Helminthosporium oryzae. RP Purkayastha, R Mukhopadhyay | 28 | 1974 |
| Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition S Roy, A Kapoor, F Zhu, R Mukhopadhyay, AK Ghosh, H Lee, J Mazzone, ... Journal of Biological Chemistry 295 (44), 15013-15028, 2020 | 18 | 2020 |
| Inhibition of cytomegalovirus replication with extended-half-life synthetic ozonides Y Wang, R Mukhopadhyay, S Roy, A Kapoor, YP Su, SA Charman, ... Antimicrobial agents and chemotherapy 63 (1), 10.1128/aac. 01735-18, 2019 | 14 | 2019 |
| Flavone-resistant Leishmania donovani overexpresses LdMRP2 transporter in the parasite and activates host MRP2 on macrophages to circumvent the flavone-mediated cell death S Chowdhury, R Mukhopadhyay, S Saha, A Mishra, S Sengupta, S Roy, ... Journal of Biological Chemistry 289 (23), 16129-16147, 2014 | 8 | 2014 |
| A novel bioimpedance-based detection of miltefosine susceptibility among clinical Leishmania donovani isolates of the Indian subcontinent exhibiting resistance to multiple drugs S Ghosh, S Biswas, S Mukherjee, A Pal, A Saxena, S Sundar, JC Dujardin, ... Frontiers in Cellular and Infection Microbiology 11, 768830, 2021 | 3 | 2021 |
Jean-Claude DujardinInstitute of Tropical MedicineVerified email at itg.be
